Surgalign Holdings Inc
F:RT2
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value of RT2.
The Intrinsic Value is calculated as the average of DCF and Relative values:
| JP |
|
Hoya Corp
TSE:7741
|
|
| CH |
|
Alcon AG
SIX:ALC
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
|
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Surgalign Holdings Inc
Balance Sheet Decomposition
Surgalign Holdings Inc
| Current Assets | 53.4m |
| Cash & Short-Term Investments | 22.4m |
| Receivables | 15.4m |
| Other Current Assets | 15.6m |
| Non-Current Assets | 14.3m |
| PP&E | 3.6m |
| Other Non-Current Assets | 10.7m |
| Current Liabilities | 20m |
| Accounts Payable | 7.5m |
| Accrued Liabilities | 12.1m |
| Other Current Liabilities | 402k |
| Non-Current Liabilities | 56.7m |
| Long-Term Debt | 10.2m |
| Other Non-Current Liabilities | 46.4m |
Free Cash Flow Analysis
Surgalign Holdings Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Surgalign Holdings Inc
|
Revenue
|
78.1m
USD
|
|
Cost of Revenue
|
-41.4m
USD
|
|
Gross Profit
|
36.8m
USD
|
|
Operating Expenses
|
-105m
USD
|
|
Operating Income
|
-68.2m
USD
|
|
Other Expenses
|
17.7m
USD
|
|
Net Income
|
-50.5m
USD
|
RT2 Profitability Score
Profitability Due Diligence
Surgalign Holdings Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.
Score
Surgalign Holdings Inc's profitability score is 15/100. The higher the profitability score, the more profitable the company is.
RT2 Solvency Score
Solvency Due Diligence
Surgalign Holdings Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Score
Surgalign Holdings Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RT2 Price Targets Summary
Surgalign Holdings Inc
Dividends
Current shareholder yield for RT2 is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?